Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Injectable progesterone after radiofrequency ablation in complicated monochorionic diamniotic twin pregnancy
IRCT20200215046496N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of hydroxyprogesterone caproate in Twin Pregnancy (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Duration of pregnancy, Preterm premature rupture of membranes and 1 more. Started Mar 2019; status: completed.
02
Drugs
hydroxyprogesterone caproate
03
Conditions
Twin Pregnancy
Beyond the preview
Go deeper on IRCT20200215046496N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200215046496N1.